XUND
PrivateLast Round
Early Funding
Mar 5, 2025
Total Funding Raised
$15.35M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
XUND operates in Healthcare & Life Sciences and is based in Vienna. Its latest recorded funding round was an Early Funding round in March 2025.
XUND is a healthtech company that develops an AI-powered technology designed to digitize the patient journey, guiding patients from prevention to diagnosis.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, NLP & Conversational AI, Patient Engagement, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
XUND Comparables
Compare XUND with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Infermedica | 86% | |
| Mediktor | 85% | |
| Ada Health | 82% |
For institutional investors. Book with your work email.
XUND Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Mar 5, 2025 | ||||
| Seed | Apr 2, 2024 | ||||
| Seed | Oct 3, 2022 | ||||
| Angel | Mar 10, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
XUND Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Peak Pride | Seed, Angel |
| Lead Ventures | Early Funding |
| RoX Health | Seed |
| MassMutual Ventures | Seed, Early Funding |
| J&T Ventures | Early Funding |
| MMC Ventures | Seed |
| 2m-quadrat AG | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 46, representing 67% of headcount.
- Jul 13, 2026
Open roles increased from 0 to 13, representing 19% of headcount.
For institutional investors. Book with your work email.
XUND Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about XUND's valuation, stock price, and market status.
Is XUND a public or private company?
XUND is a private company.
What is the current stock price of XUND?
XUND is a private company, so its shares have no public market price. Caplight tracks XUND's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is XUND worth (valuation)?
Valuation information for XUND is not publicly available.
Can I buy XUND stock?
XUND shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was XUND's last funding round?
XUND's most recent funding round was Early Funding on March 5, 2025.
Who are the main investors in XUND?
Key investors in XUND include Peak Pride, Lead Ventures, MassMutual Ventures, MMC Ventures.
Will XUND IPO soon?
No public IPO plans have been announced for XUND.
How can I track XUND secondary market activity?
Caplight tracks bids, offers, and trades in XUND's shares on secondary markets.